Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 10:47 PM
Study NCT ID:
NCT01773967
Status:
COMPLETED
Last Update Posted:
2019-09-06
First Post:
2013-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis
Sponsor:
Washington University School of Medicine
Organization:
Study Overview
Official Title:
Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will study the efficacy and side effect profile of LGG, a probiotic, in pediatric patients with acute gastroenteritis.
Detailed Description:
Multicenter randomized controlled trial of LGG in patients 3-48 months of age presenting to the Emergency Department with acute gastroenteritis.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: